Royal UNIBREW A/S
9.3.2026 12:17:18 CET | Globenewswire | Press release
Share buy-back program
Share buy-back program
COMPANY ANNOUNCEMENT NO 5/2026 - March 9, 2026
On February 26, 2026, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 3/2026.
The share buy-back program will be executed under EU Commission Regulation No. 596/2014 of the European Parliament and Council of April 16, 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”).
The share buy-back program is expected to be realized in the period from February 27, 2026, to August 14, 2026. The total transaction value of the share buy-backs in the period will not exceed DKK 400m.
The following transactions have been made under the program:
| Number of Shares | Average purchase price DKK | Transaction value, DKK | |
| Accumulated, last announcement | 0 | 0 | |
| February 27, 2026 | 7,000 | 614.61 | 4,302,270 |
| March 2, 2026 | 7,000 | 612.28 | 4,285,960 |
| March 3, 2026 | 9,000 | 601.76 | 5,415,840 |
| March 4, 2026 | 9,000 | 608.30 | 5,474,700 |
| March 5, 2026 | 10,000 | 600.41 | 6,004,100 |
| March 6, 2026 | 11,000 | 589.72 | 6,486,920 |
| Total accumulated under the program | 53,000 | 603.20 | 31,969,790 |
With the transactions stated above Royal Unibrew owns a total of 1,206,387 shares,
corresponding to 2.4% of the share capital. The total amount of shares in the company is 50,200,000, including treasury shares.
For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail: Flemming.Nielsen@royalunibrew.com
Telephone: +45 25 41 68 04
Encl.
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
BYD9.3.2026 15:19:24 CET | Press release
BYD breaks down final barriers to electrification with Blade Battery 2.0 and FLASH Charging
Menarini9.3.2026 15:18:25 CET | Press release
Menarini nears €4.9 billion in 2025 and focuses on talent and AI as ‘giant’ players enter pharma
Genmab A/S9.3.2026 15:01:08 CET | Press release
Transactions in Connection with Share Buy-back Program
Netcompany Group A/S9.3.2026 14:44:37 CET | Press release
How AI is affecting our industry - Q&A with CEO André Rogaczewski
Esaote9.3.2026 14:15:58 CET | Press release
Esaote launches the new MyLabTM E85 GTS ultrasound system in Vienna
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom